Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Response to Cardiac Resynchronization Therapy in Heart Failure

NCT00359372 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00359372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00359372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Completed
Start date
July 28, 2006
Completion date
May 29, 2007
Enrollment
180
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, left ventricular dysfunction